Viewing StudyNCT05641545



Ignite Creation Date: 2024-05-06 @ 6:23 PM
Last Modification Date: 2024-10-26 @ 2:47 PM
Study NCT ID: NCT05641545
Status: TERMINATED
Last Update Posted: 2022-12-07
First Post: 2022-05-02

Brief Title: IVAC-RCC-001 A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in AdvancedMetastatic RCC Patients
Sponsor: SLK Kliniken Heilbronn GmbH
Organization: SLK Kliniken Heilbronn GmbH

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-10-17
Start Date Type: ACTUAL
Primary Completion Date: 2024-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-11
Completion Date Type: ESTIMATED
First Submit Date: 2022-05-02
First Submit QC Date: November 30 2022
Study First Post Date: 2022-12-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-15
Last Update Post Date: 2022-12-07
Last Update Post Date Type: ACTUAL